HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹522 Cr | ₹550 Cr | ₹442 Cr | ₹438 Cr | ₹486 Cr |
What is the latest Sundry Debtors ratio of HIKAL ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹522 Cr |
| Mar2024 | ₹550 Cr |
| Mar2023 | ₹442 Cr |
| Mar2022 | ₹438 Cr |
| Mar2021 | ₹486 Cr |
How is Sundry Debtors of HIKAL Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹522 Cr | -5.07 | |
| Mar2024 | ₹550 Cr | 24.56 | |
| Mar2023 | ₹442 Cr | 0.93 | |
| Mar2022 | ₹438 Cr | -9.85 | |
| Mar2021 | ₹486 Cr | - | |
Compare Sundry Debtors of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,233.0 Cr | -7.8% | -7.7% | -47.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -7.8% |
-7.7% |
-47.6% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses